Spots Global Cancer Trial Database for neoplasms, colorectal
Every month we try and update this database with for neoplasms, colorectal cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT05358249 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... Nonsmall Cell L... Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Tumo... Neoplasms, Colo... | JDQ443 trametinib Ribociclib cetuximab | 18 Years - | Novartis | |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer | NCT00478634 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | RAD001, Cetuxim... | 18 Years - 65 Years | Novartis | |
| Physically Active During Cancer Treatment (FAKT) | NCT03885817 | Neoplasms, Colo... | Exercise traini... Standard follow... | 18 Years - | St. Olavs Hospital | |
| Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies | NCT00081536 | Colorectal Neop... | Aroplatin (Lipo... | 18 Years - | Aronex Pharmaceuticals | |
| Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth | NCT01632020 | Colorectal Neop... | Placebo Metformin | 18 Years - | University of Arkansas | |
| Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer | NCT00536809 | Neoplasms, Colo... | lapatinib oxaliplatin capecitabine | 18 Years - | GlaxoSmithKline | |
| A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies | NCT00043199 | Colorectal Neop... | Aroplatin (Lipo... | 18 Years - | Aronex Pharmaceuticals | |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study | NCT00704600 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | nelfinavir | 18 Years - | Maastricht Radiation Oncology | |
| A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases | NCT00920803 | Neoplasms, Colo... | Placebo SRT501 | 18 Years - | GlaxoSmithKline | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | NCT00387387 | Neoplasms, Colo... | Pazopanib FOLFOX 6 CapeOx | 21 Years - | GlaxoSmithKline | |
| Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement | NCT06118125 | Neoplasms, Colo... General Practit... Pandemic, COVID... Neoplasm, Liver Neoplasms Pancr... Diagnosis Advanced Cancer | 18 Years - | University of Bordeaux | ||
| Safety and Effectiveness of Regorafenib | NCT02042144 | Neoplasms | Stivarga (Regor... | 18 Years - | Bayer | |
| Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT05358249 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... Nonsmall Cell L... Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Tumo... Neoplasms, Colo... | JDQ443 trametinib Ribociclib cetuximab | 18 Years - | Novartis | |
| Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer | NCT00540943 | Neoplasms, Colo... | Pazopanib Cetuximab Irinotecan | 18 Years - | GlaxoSmithKline | |
| Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients | NCT01157052 | Neoplasms, Colo... Colorectal Canc... Colorectal Carc... | (supplement) Ca... | 18 Years - | AHS Cancer Control Alberta | |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) | NCT01671592 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | DC Vaccine | 18 Years - | University of Pittsburgh | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Colorectal Laterally Spreading Lesions. | NCT04593407 | Neoplasms, Colo... | Endoscopic muco... Endoscopic subm... | 18 Years - 85 Years | Hospital Universitario 12 de Octubre | |
| Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies | NCT00081536 | Colorectal Neop... | Aroplatin (Lipo... | 18 Years - | Aronex Pharmaceuticals | |
| Study Evaluating MAC-321 in Colorectal Cancer | NCT00063427 | Colorectal Neop... Colonic Neoplas... Rectal Neoplasm... | MAC-321 | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer | NCT00540943 | Neoplasms, Colo... | Pazopanib Cetuximab Irinotecan | 18 Years - | GlaxoSmithKline | |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) | NCT01671592 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | DC Vaccine | 18 Years - | University of Pittsburgh | |
| Safety and Effectiveness of Regorafenib | NCT02042144 | Neoplasms | Stivarga (Regor... | 18 Years - | Bayer | |
| Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer | NCT00558051 | Metastatic Colo... | DC-based vaccin... DC-based vaccin... DC-based vaccin... | 18 Years - 80 Years | University of Pittsburgh | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Study Evaluating EKB-569 in Advanced Colorectal Cancer | NCT00072748 | Colorectal Neop... Colonic Neoplas... Rectal Neoplasm... | EKB-569 | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement | NCT06118125 | Neoplasms, Colo... General Practit... Pandemic, COVID... Neoplasm, Liver Neoplasms Pancr... Diagnosis Advanced Cancer | 18 Years - | University of Bordeaux | ||
| Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | NCT00387387 | Neoplasms, Colo... | Pazopanib FOLFOX 6 CapeOx | 21 Years - | GlaxoSmithKline | |
| A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases | NCT00920803 | Neoplasms, Colo... | Placebo SRT501 | 18 Years - | GlaxoSmithKline |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
